Cite
MLA Citation
Ian Catlett et al.. “225 An oral, selective inhibitor of tyrosine kinase 2, BMS-986165, improves molecular, cellular, and clinical biomarkers associated with efficacy in moderate to severe psoriasis.” Lupus science & medicine, vol. 6, n.d., p. A169. http://access.bl.uk/ark:/81055/vdc_100144721698.0x000002